Search by Drug Name or NDC
NDC 00990-7372-62 Ionosol MB and Dextrose 5; 30; 15; 141; 260; 25 g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL Details
Ionosol MB and Dextrose 5; 30; 15; 141; 260; 25 g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL
Ionosol MB and Dextrose is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ICU Medical Inc.. The primary component is DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; MONOBASIC POTASSIUM PHOSPHATE; POTASSIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE.
Product Information
| NDC | 00990-7372 |
|---|---|
| Product ID | 0990-7372_a45a4764-7b27-447b-a835-3ac429351b85 |
| Associated GPIs | 79993002782010 |
| GCN Sequence Number | 001957 |
| GCN Sequence Number Description | electrolyte-MB solution/D5W IV SOLN 5 % INTRAVEN |
| HIC3 | C1W |
| HIC3 Description | ELECTROLYTE MAINTENANCE |
| GCN | 62160 |
| HICL Sequence Number | 014857 |
| HICL Sequence Number Description | ELECTROLYTE-MB SOLUTION/DEXTROSE 5 % IN WATER |
| Brand/Generic | Brand |
| Proprietary Name | Ionosol MB and Dextrose |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, and SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 5; 30; 15; 141; 260; 25 |
| Active Ingredient Units | g/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Substance Name | DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; MONOBASIC POTASSIUM PHOSPHATE; POTASSIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Labeler Name | ICU Medical Inc. |
| Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition L |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019513 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00990-7372-62 (00990737262)
| NDC Package Code | 0990-7372-62 |
|---|---|
| Billing NDC | 00990737262 |
| Package | 24 POUCH in 1 CASE (0990-7372-62) / 1 BAG in 1 POUCH / 250 mL in 1 BAG |
| Marketing Start Date | 2019-07-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |